Know Cancer

or
forgot password

Ultrasound With Contrast Agent, 64-Slice-CT and Tumormarkers for Diagnosing, Evaluation of Operability and Treatment Control of Pancreas Cancer


N/A
N/A
N/A
Open (Enrolling)
Both
Pancreas Cancer

Thank you

Trial Information

Ultrasound With Contrast Agent, 64-Slice-CT and Tumormarkers for Diagnosing, Evaluation of Operability and Treatment Control of Pancreas Cancer


Inclusion Criteria:



- suspicion of cancer of the pancreas

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Diagnostic

Principal Investigator

Michael B Nielsen, DMSc

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Radiology, Section of Ultrasound

Authority:

Denmark: Ethics Committee

Study ID:

(KF) 01 268342

NCT ID:

NCT00259532

Start Date:

February 2005

Completion Date:

January 2009

Related Keywords:

  • Pancreas Cancer
  • Pancreatic Neoplasms

Name

Location